- Browse by Author
Browsing by Author "Alaswad, Rehab"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia(Springer, 2022-06) Almudarra, Sami; Kamel, Shady; Saleh, Eman; Alaswad, Rehab; Alruwaily, Amaal; Almowald, Shaza; Alqunaibet, Ada Mohammed; Almudiaheem, Abdullah; Almutlaq, Hind; Alserehi, Haleema; Almalki, Safar; Bahlaq, Mohannad Abdulhafiz; Alsahafi, Abdullah Jaber; Alsaif, Faisal; Khojah, Abdullah T.; Al‑Tawfiq, Jaffar A.; Asiri, Sari Ibrahim; Assiri, Abdullah; Jokhdar, Hani; Medicine, School of MedicineBackground: The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection had been investigated utilizing serology. Materials and methods: This community-based sero-survey was carried out in the neighborhoods of three cities in Saudi Arabia. Results: Of 5629 participants, 2766 (49.1%) were women; and 2148 (38.1%) were 18-34 years of age, and 3645 (64.7%) were from South East Asia. Positive serology was seen in 2825 (50.2% (95% CI: 48.8-51.5%) for SARS-CoV-2 anti-S1 IgG antibodies by ECLIA. Being in the age category of 18-34 years and being from Eastern Mediterranean Region (country A) were associated with higher COVID-19 seropositivity with estimated odds ratio of 1.3 [95% CI 1.1-1.8] and 2.5 [95% CI 1.1.5-4.2] respectively. Gender, social status, education, nationality, symptoms, presence of comorbidities and activity style were positively associated with increased seropositivity. Factors associated negatively with the rate of seropositivity were higher education and having outdoor activity with estimated OR of 0.92 [95% CI 0.46-0.95] and 0.59 [95% CI 0.47-0.74], respectively. Conclusion: The study showed high seroprevalence of SARS-CoV-2 among high density population. Health education campaigns should target middle-aged, those with low education, those living in lower standards and indoor workers.Item Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early month of the pandemic in Saudi Arabia(Elsevier, 2020) Banjar, Ayman; Al-Tawfiq, Jaffar A.; Alruwaily, Amaal; Alserehi, Haleema; Al-Qunaibet, Ada; Alaswad, Rehab; Almutlaq, Hind; Almudaiheem, Abdullah; Khojah, Abdullah T.; Alsaif, Faisal; Almolad, Shaza Karim; Alqahtani, Saeed; AlJurayyan, Abdullah; Alotaibi, Abdullah; Almalki, Safar; Abuhaimed, Yousef; Alkhashan, Abdullah; Alfaifi, Amal; Alabdulkareem, Khaled; Jokhdar, Hani; Assiri, Abdullah; Almudarra, Sami; Medicine, School of MedicineBackground: Serologic testing provides better understanding of SARS-CoV-2 prevalence and its transmission. This study was an investigation of the prevalence of antibodies to SARS-CoV-2 among blood donors in Saudi Arabia. Objective: To estimate the seroprevalence of anti-SARS-CoV-2 antibodies among blood donors in Saudi Arabia during the early phase of the COVID-19 pandemic. Methods: Serology results and epidemiological data were analyzed for 837 adult blood donors, with no confirmed SARS-CoV-2 infection, in Saudi Arabia from 20th to 25th May 2020. Seroprevalence was determined using electrochemical immunoassay to detect anti-SARS-CoV-2 antibodies. Results: The overall seroprevalence of anti-SARS-CoV-2 antibodies was 1.4% (12/837). Non-citizens had higher seroprevalence compared with citizens (OR 13.6, p = 0.001). Secondary education was significantly associated with higher seroprevalence compared with higher education (OR 6.8, p = 0.005). The data showed that the highest seroprevalence was in Makkah (8.1%). Uisng Makkah seroprevalence as the reference, the seroprevalence in other areas was: Madinah 4.1% (OR 0.48, 95% CI 0.12-1.94), Jeddah 2.3% (OR 0.27, 95% CI 0.31-2.25), and Qassim 2.9 % (OR 0.34, 95% CI 0.04-2.89) and these were not statistically different from seroprevalence in the Makkah region. Conclusions: At the early months of the COVID-19 pandemic in Saudi Arabia, the seroprevalence of antibodies to SARS-CoV-2 among blood donors was low, but was higher among non-citizens. These findings may indicate that non-citizens and less educated individuals may be less attentive to preventive measures. Monitoring seroprevalence trends over time require repeated sampling.